Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Systemic (AL) Amyloidosis”

Showing 7 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07335887
What this trial is testing

Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis

Who this might be right for
AL Amyloidosis (AL)t(11;14) Positive
Peking University People's Hospital 39
Testing effectiveness (Phase 2)Study completedNCT00064337
What this trial is testing

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network 104
Large-scale testing (Phase 3)Study completedNCT00344526
What this trial is testing

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis (AL)
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00520767
What this trial is testing

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Who this might be right for
Primary Systemic AmyloidosisLight Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute 35
Testing effectiveness (Phase 2)Study completedNCT01527032
What this trial is testing

Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis

Who this might be right for
Amyloidosis
FDA Office of Orphan Products Development
Testing effectiveness (Phase 2)Study completedNCT00547365
What this trial is testing

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
University of Tennessee 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation